Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Cleveland Clinic Journal of Medicine|January 5, 2002
GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell usD P Chew, D J MoliternoJournal of the American College of Cardiology|December 29, 2000
A critical appraisal of platelet glycoprotein IIb/IIIa inhibitionD P Chew, D J MoliternoJAMA|September 23, 2000
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesD L Bhatt, E J TopolMinerva Cardioangiologica|October 11, 2003
The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridinesJ C Hostetter, D L BhattThe Medical Clinics of North America|February 24, 2000
Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart diseaseD L Bhatt, E J TopolProgress in Cardiovascular Diseases|December 1, 2001
Intravenous glycoprotein IIb/IIIa inhibition in non-ST segment elevation acute coronary syndromesD P Chew, M Roffi, E J TopolInternational Journal of Cardiology|December 17, 2021
Outcome trial data on sodium glucose cotransporter-2 inhibitors: Putting clinical benefits and risks in perspectiveB Chiang, D P Chew, C G De PasqualeCirculation|December 6, 2001
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromesM Roffi, D P Chew, D Mukherjee, et al.European Heart Journal|September 5, 2002
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategyM Roffi, D P Chew, D Mukherjee, et al.Internal Medicine Journal|May 31, 2007
Improving the management of acute coronary syndromes in Australia: translating evidence to outcomesL T Huynh, P A Phillips, D P ChewPageof 8